Table 3.
Treatment-specific symptoms and general functioning predicting change in physical activity during weight loss (0–6 months)
| DV: bouted MVPA min/weeka | |||
|---|---|---|---|
| Variable | F | Partial Eta squared | P value |
| Baseline BCPT Musculoskeletal |
.764 | .005 | .383 |
| Baseline BCPT Vasomotor | .250 | .002 | .618 |
| Baseline BCPT Cognitive | 1.552 | .009 | .215 |
| Baseline SF-12 Physical | 4.063 | .024 | .045 |
| Baseline SF-12 Mental | 1.210 | .007 | .273 |
Note: Model included the following covariates: age, baseline anti-hormone therapy, chemotherapy treatment history, time since treatment completion, education, rurality, and baseline BMI.
a
Dependent variable was square-root transformed
BCPT = Breast Cancer Prevention Trial Symptom Checklist
MVPA = moderate to vigorous physical activity